C
CorMedix D
D
CRMD
11.725
USD
0.39
(3.40%)
قبل الجلسة
حجم التداول
54
الربح لكل سهم
1
العائد الربحي
-
P/E
47
حجم السوق
872,681,971
الأخبار المقالات
العنوان: CorMedix
القطاع: Healthcare
الصناعة: Biotechnology
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.